Clinical trials
Hernia, Hiatal trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
83 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2002 | 2 |
| 2004 | 2 |
| 2005 | 1 |
| 2006 | 2 |
| 2007 | 2 |
| 2008 | 1 |
| 2009 | 1 |
| 2010 | 3 |
| 2011 | 1 |
| 2012 | 2 |
| 2013 | 2 |
| 2014 | 3 |
| 2015 | 3 |
| 2016 | 7 |
| 2018 | 1 |
| 2019 | 3 |
| 2020 | 4 |
| 2021 | 7 |
| 2022 | 2 |
| 2023 | 11 |
| 2024 | 9 |
| 2025 | 7 |
| 2026 | 4 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 40 |
| Recruiting | 14 |
| Unknown status | 13 |
| Not yet recruiting | 8 |
| Active, not recruiting | 4 |
| Terminated | 2 |
| Enrolling by invitation | 1 |
| Withdrawn | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| University of Bologna | 4 |
| EndoGastric Solutions | 3 |
| Minia University | 3 |
| Beijing Friendship Hospital | 2 |
| Foregut Research Foundation | 2 |
| Karolinska Institutet | 2 |
| Karolinska University Hospital | 2 |
| M.S.T. Medical Surgery Technology LTD. | 2 |
| Mayo Clinic | 2 |
| National Taiwan University Hospital | 2 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Hernia, Hiatal | 83 |
| Gastroesophageal Reflux | 36 |
| Hernia | 7 |
| Recurrence | 5 |
| Esophagitis | 4 |
| Barrett Esophagus | 3 |
| Esophagitis, Peptic | 3 |
| Deglutition Disorders | 2 |
| Esophageal Achalasia | 2 |
| Heartburn | 2 |
Trials
Showing 76 to 83 of 83. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.